NEW YORK, Dec 18 – Zyomyx and MDS Proteomics said Monday they had agreed to jointly study protein pathways as part of an effort to improve cell research.

Under the terms of the deal, Zyomyx will contribute its protein chip technology and MDS will contribute its protein pathway identification and analysis experience to prove the efficacy of using protein biochips in mass spectrometry-based proteomic studies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.